EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study

Agnes Sze-Yin Leung iD, Yanjun Gu iD, Ann Wing-Shan Au, Rosetta Tsz-Ching Leung, Vanessa Hiu-Tung Tang, Kin Yi Fung, Janice Min Li iD, Christine Yee-Yan Wai iD, Ting Fan Leung iD, Gary Wing-Kin Wong iD

Allergy · 2026

DOI: 10.1111/all.70268 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Allergy, 2026. Verfasst von Agnes Sze-Yin Leung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Allergens, Food Hypersensitivity, Fish Proteins. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council of the Hong Kong Special Administrative Region, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For young children with fish allergy, dietary avoidance is the current standard of care. We aimed to assess whether codfish oral immunotherapy (OIT) can induce desensitization or sustained unresponsiveness (SU) in this population.

Methods

We conducted a randomized, double‐blind, placebo‐controlled study in Hong Kong. Children aged 2–10 years reactive to codfish protein during DBPCFC were randomly assigned 1:1 to codfish OIT or placebo for 52 weeks (1000 mg daily maintenance) followed by 8 weeks avoidance. Primary outcome was desensitization at week 52; sustained unresponsiveness (SU) at week 60 was a key secondary outcome.

Results

Between November 2022–September 2023, 70 children (median age 5.6 years) were randomized to codfish OIT ( n = 35) or placebo ( n = 35). At the week 52 end‐of‐treatment challenges, 15 (43%) OIT participants versus 4 (11%) placebo achieved desensitization (risk difference 32%, 95% CI 9%–51%; p = 0.003), with significantly greater increases in cumulative tolerated protein [median 4330 mg vs. 0 mg, p < 0.001]. At week 60, SU rates were 8 (23%) versus 3 (9%) (risk difference 14%, 95% CI −5% to 33%; p = 0.332). Codfish OIT significantly decreased codfish‐specific IgE, rGad c1‐specific IgE, and skin reactivity while increasing codfish‐specific IgG4. The treatment demonstrated acceptable safety with minimal moderate‐to‐severe adverse events and epinephrine use (3% both groups), and immunological evidence of reduced cross‐reactivity to salmon and catfish allergens.

Conclusions

In children with fish allergy, codfish OIT significantly increased desensitization rates compared to avoidance, though SU remained limited. The treatment demonstrated acceptable safety with predominantly mild reactions and reduced IgE cross‐reactivity to other fish allergens. Trial Registration ClinicalTrials.gov identifier: NCT05590299

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicAllergensFood HypersensitivityFish ProteinsHumansMaleAnimalsFemaleChild, PreschoolAdministration, OralChildImmunoglobulin ETreatment OutcomeDouble-Blind Method

Stichwörter der Autor:innen

allergen immunotherapycodfish allergydesensitization therapyoral immunotherapyrandomized controlled trial

Substanzen

AllergensImmunoglobulin EFish Proteins

Autor:innen und Institutionen

  • Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Hong Kong Hub of Paediatric Excellence (HOPE), The Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Agnes Sze-Yin Leung, Yanjun Gu, Janice Min Li, Christine Yee-Yan Wai, Ting Fan Leung, Gary Wing-Kin Wong

Förderung

  • Research Grants Council of the Hong Kong Special Administrative Region, China

Zitieren

APA

Leung, A. S., Gu, Y., Au, A. W., Leung, R. T., Tang, V. H., Fung, K. Y., Li, J. M., Wai, C. Y., Leung, T. F., & Wong, G. W. (2026). Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study. Allergy. https://doi.org/10.1111/all.70268

Vancouver

Leung AS, Gu Y, Au AW, Leung RT, Tang VH, Fung KY, et al. Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study. Allergy. 2026. doi:10.1111/all.70268

BibTeX
@article{Leung2026,
  author = {Leung, Agnes Sze-Yin and Gu, Yanjun and Au, Ann Wing-Shan and Leung, Rosetta Tsz-Ching and Tang, Vanessa Hiu-Tung and Fung, Kin Yi and Li, Janice Min and Wai, Christine Yee-Yan and Leung, Ting Fan and Wong, Gary Wing-Kin},
  title = {Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70268}
}
Kostenlos starten →